Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 29;10(3):e0236921.
doi: 10.1128/spectrum.02369-21. Epub 2022 May 23.

Investigation of the Involvement of HHV-6 Encoded Viral Chemokine Receptors in Autoimmune Thyroiditis Development

Affiliations

Investigation of the Involvement of HHV-6 Encoded Viral Chemokine Receptors in Autoimmune Thyroiditis Development

Alina Sultanova et al. Microbiol Spectr. .

Abstract

Human herpesvirus-6 (HHV-6) contains two genes (U12 and U51) that encode putative homologues of human G-protein-coupled receptors like CCR1, CCR3, and CCR5. It has been shown that these viral proteins can be expressed on the surface of epithelial and some peripheral blood mononuclear cells, suggesting that they could potentially induce autoimmunity. We aimed to investigate the possibility of HHV-6 encoded viral chemokine receptors (U12 and U51) involvement in autoimmune thyroiditis (AIT) development by detecting viral peptide specific antibodies in AIT patient samples. Seventy-nine AIT patients whose thyroid tissues were shown to be positive for HHV-6 and 32 blood donors were enrolled in this study. Twenty-eight synthetic peptides derived from HHV-6 U12 and U51 proteins' amino acid sequences, as well as recombinant human CCR1, CCR3, and CCR5 proteins were used in suspension multiplex immunological assay to detect specific IgG and IgM antibodies. HHV-6 peptide specific IgG and IgM antibodies were found in patients' samples. AIT patients' samples were found to be more frequently positive for peptide IgGs in comparison to control group's samples. Even though peptide antibody cross-reactivity with human CCRs was not demonstrated, our results show a new immunogenic HHV-6 antigen-a possible new player in the HHV-6 induced autoimmunity exacerbation. IMPORTANCE The study of human herpesvirus-6 (HHV-6) involvement in autoimmunity development is very challenging, due to the complex nature of this virus. HHV-6 is a ubiquitous, lifelong persistent, and immunomodulating virus, which mainly spreads in solid tissues using cell-to-cell mechanics, and thus can escape from the host's immune response. It has been implicated as an environmental factor in several autoimmune diseases. An association between HHV-6 and autoimmune thyroiditis has been demonstrated, yet clear mechanism of involvement remains to be elucidated, since the virus can be detected in nearly all autoimmune thyroiditis patient thyroid glands. Our results show new potentially immunogenic human herpesvirus-6 antigens-possible new players in the HHV-6 induced autoimmunity exacerbation, which could be subjects for further research. Together with previously published results, this study described possible mechanisms which may underlie the induction of autoimmune reactivities against thyroid tissues in AIT.

Keywords: G protein-coupled receptors; HHV-6; antibodies; autoimmune thyroiditis; chemokine receptor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
SMIA results of IgG antibodies against 8 immunogenic HHV-6 synthetic peptides in AIT patients’ and blood donors’ groups (*, significant difference).
FIG 2
FIG 2
SMIA results of IgM antibodies against 10 immunogenic HHV-6 synthetic peptides in AIT patients’ and blood donors’ groups (*, significant difference).
FIG 3
FIG 3
HHV-6 load in thyroid gland tissues found in AIT patients negative and positive for synthetic peptide IgGs.
FIG 4
FIG 4
Thyroid auto-antibody levels (TPO or TG) in AIT patients negative and positive for synthetic peptide IgGs.

Similar articles

Cited by

References

    1. Yagasaki H, Kato M, Shimizu N, Shichino H, Chin M, Mugishima H. 2011. Autoimmune hemolytic anemia and autoimmune neutropenia in a child with erythroblastopenia of childhood (TEC) caused by human herpesvirus-6 (HHV-6). Ann Hematol 90:851–852. doi:10.1007/s00277-010-1095-x. - DOI - PubMed
    1. Grima P, Chiavaroli R, Calabrese P, Tundo P, Grima P. 2008. Severe hepatitis with autoimmune features following a HHV-6: a case report. Cases J 1:110. doi:10.1186/1757-1626-1-110. - DOI - PMC - PubMed
    1. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M. 2003. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 69:111–117. doi:10.1002/jmv.10258. - DOI - PubMed
    1. Nora-Krukle Z, Chapenko S, Logina I, Millers A, Platkajis A, Murovska M. 2011. Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Med Kaunas Lith 47:527–531. - PubMed
    1. Tejada-Simon MV, Zang YCQ, Hong J, Rivera VM, Zhang JZ. 2003. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 53:189–197. doi:10.1002/ana.10425. - DOI - PubMed

Publication types